
Stephone B. Allen
Supervisory Patent Examiner (ID: 17334, Phone: (571)272-2434 , Office: P/2872 )
| Most Active Art Unit | 2878 |
| Art Unit(s) | 2505, 2872, 2878, 2899, 2507, 2509 |
| Total Applications | 2150 |
| Issued Applications | 1787 |
| Pending Applications | 126 |
| Abandoned Applications | 238 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 173914
[patent_doc_number] => 07659293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'α-Amino-N-hydroxy-acetamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/868032
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10969
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659293.pdf
[firstpage_image] =>[orig_patent_app_number] => 11868032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/868032 | α-Amino-N-hydroxy-acetamide derivatives | Oct 4, 2007 | Issued |
Array
(
[id] => 4939614
[patent_doc_number] => 20080076933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'PROCESS FOR MAKING ANASTROZOLE'
[patent_app_type] => utility
[patent_app_number] => 11/859149
[patent_app_country] => US
[patent_app_date] => 2007-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4130
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11859149
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/859149 | PROCESS FOR MAKING ANASTROZOLE | Sep 20, 2007 | Abandoned |
Array
(
[id] => 4442530
[patent_doc_number] => 07928129
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-04-19
[patent_title] => 'Nanomolar β-lactamase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/901810
[patent_app_country] => US
[patent_app_date] => 2007-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 19538
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/928/07928129.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901810
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901810 | Nanomolar β-lactamase inhibitors | Sep 17, 2007 | Issued |
Array
(
[id] => 4720171
[patent_doc_number] => 20080242694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith'
[patent_app_type] => utility
[patent_app_number] => 11/901598
[patent_app_country] => US
[patent_app_date] => 2007-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61118
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242694.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901598 | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith | Sep 16, 2007 | Abandoned |
Array
(
[id] => 6223988
[patent_doc_number] => 20100056779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'SYNTHESIS OF METHYL NONACTATE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/441140
[patent_app_country] => US
[patent_app_date] => 2007-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1257
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441140
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441140 | Synthesis of methyl nonactate derivatives | Sep 10, 2007 | Issued |
Array
(
[id] => 6511954
[patent_doc_number] => 20100210852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL'
[patent_app_type] => utility
[patent_app_number] => 12/668618
[patent_app_country] => US
[patent_app_date] => 2007-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2718
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210852.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668618
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668618 | PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL | Aug 29, 2007 | Abandoned |
Array
(
[id] => 6568465
[patent_doc_number] => 20100234378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'ALKYLSULFONAMIDE-SUBSTITUTED TRIAZOLES AS MATRIX METALLOPROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/438339
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13044
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234378.pdf
[firstpage_image] =>[orig_patent_app_number] => 12438339
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/438339 | ALKYLSULFONAMIDE-SUBSTITUTED TRIAZOLES AS MATRIX METALLOPROTEASE INHIBITORS | Aug 20, 2007 | Abandoned |
Array
(
[id] => 6549228
[patent_doc_number] => 20100233116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/377499
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96607
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233116.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377499 | Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels | Aug 12, 2007 | Issued |
Array
(
[id] => 330573
[patent_doc_number] => 07511069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Indazole compounds as β3 andrenoceptor agonist'
[patent_app_type] => utility
[patent_app_number] => 11/837054
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20112
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/511/07511069.pdf
[firstpage_image] =>[orig_patent_app_number] => 11837054
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/837054 | Indazole compounds as β3 andrenoceptor agonist | Aug 9, 2007 | Issued |
Array
(
[id] => 6308269
[patent_doc_number] => 20100069629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/376039
[patent_app_country] => US
[patent_app_date] => 2007-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 208542
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376039
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376039 | Pyrimidine derivatives as PI3K inhibitor and use thereof | Aug 6, 2007 | Issued |
Array
(
[id] => 9312059
[patent_doc_number] => 08653278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Isoform selective HDAC inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/375348
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 36592
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12375348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375348 | Isoform selective HDAC inhibitors | Aug 1, 2007 | Issued |
Array
(
[id] => 8571301
[patent_doc_number] => 08337941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Fluorescent substrates for monoamine transporters as optical false neurotransmitters'
[patent_app_type] => utility
[patent_app_number] => 12/309724
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 36
[patent_no_of_words] => 18158
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12309724
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309724 | Fluorescent substrates for monoamine transporters as optical false neurotransmitters | Jul 26, 2007 | Issued |
Array
(
[id] => 296104
[patent_doc_number] => 07541375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Azole derivatives and pharmaceutical compositions containing them'
[patent_app_type] => utility
[patent_app_number] => 11/782251
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 15097
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541375.pdf
[firstpage_image] =>[orig_patent_app_number] => 11782251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/782251 | Azole derivatives and pharmaceutical compositions containing them | Jul 23, 2007 | Issued |
Array
(
[id] => 8328692
[patent_doc_number] => 08236788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same'
[patent_app_type] => utility
[patent_app_number] => 12/374710
[patent_app_country] => US
[patent_app_date] => 2007-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13980
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12374710
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/374710 | Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same | Jul 17, 2007 | Issued |
Array
(
[id] => 334343
[patent_doc_number] => 07507755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-24
[patent_title] => 'Inhibitors of cathepsin s'
[patent_app_type] => utility
[patent_app_number] => 11/777879
[patent_app_country] => US
[patent_app_date] => 2007-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21902
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/507/07507755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11777879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/777879 | Inhibitors of cathepsin s | Jul 12, 2007 | Issued |
Array
(
[id] => 5496402
[patent_doc_number] => 20090264430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Salt of morpholine compound'
[patent_app_type] => utility
[patent_app_number] => 12/309196
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4439
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264430.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309196
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309196 | Salt of morpholine compound | Jul 10, 2007 | Issued |
Array
(
[id] => 4652209
[patent_doc_number] => 20080039465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'TRIAZOLYL PHENYL BENZENESULFONAMIDES'
[patent_app_type] => utility
[patent_app_number] => 11/775585
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39368
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775585 | Triazolyl phenyl benzenesulfonamides | Jul 9, 2007 | Issued |
Array
(
[id] => 4909176
[patent_doc_number] => 20080019942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION'
[patent_app_type] => utility
[patent_app_number] => 11/773912
[patent_app_country] => US
[patent_app_date] => 2007-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43500
[patent_no_of_claims] => 158
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20080019942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11773912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/773912 | Inhibitors of hepatitis C virus replication | Jul 4, 2007 | Issued |
Array
(
[id] => 5279124
[patent_doc_number] => 20090131256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/305419
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49449
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131256.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305419
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305419 | Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds | Jun 28, 2007 | Issued |
Array
(
[id] => 5316728
[patent_doc_number] => 20090281326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'Process For the Preparation of Angiotensin II Antagonist'
[patent_app_type] => utility
[patent_app_number] => 12/309016
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2355
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281326.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309016
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309016 | Process for the preparation of angiotensin II antagonist | Jun 28, 2007 | Issued |